Perspective Therapeutics (CATX) stock
Breakaway doesn't score CATX. It is priced too low for a fair Quality Score.
Follow CATX's trial news. Pro members can get an alert when Perspective Therapeutics files news, and see its trials, share raises, and its CEO's filings.
We do the work for you. 3,168 stocks are scored and ranked, every 15 seconds while the market is open. Pro members see it live.
What's next for CATX, and how long its cash lasts
Next step the company has named
Cash runway
About 7 quarters
Dilution on the horizon
- Shelf registration (S-3ASR, filed May 24, 2024)
- At-the-market share sales program (424B5, filed Aug 13, 2024)
Insiders
Chief Accounting Officer Jonathan Robert Hunt bought 11,000 shares on Nov 13, 2025.
FDA dates in the next 60 days
Decision dates and advisory committee meetings the companies have announced in their filings, soonest first and small companies first.
CATX's latest filings
- Quarterly report
- Perspective Therapeutics Provides Recent Business Highlights and Reports 3Q 2026 Results
- An insider's trade or award
Why CATX isn't scored
The Quality Score reads US-listed stocks worth $50M or more that trade at $1 or more and 300,000 shares or $10M a day. CATX trades at $0.79. A stock that clears every mark is scored from the next weekly rebuild.
Straight AnswersStraight Answers
Are the prices delayed?
Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.